Jpmorgan Chase & CO Amneal Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,214,972 shares of AMRX stock, worth $10.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,214,972
Previous 1,297,094 6.33%
Holding current value
$10.5 Million
Previous $10.8 Million 10.83%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$7.69 - $9.25 $631,518 - $759,628
-82,122 Reduced 6.33%
1,214,972 $9.62 Million
Q3 2024

Dec 26, 2024
BUY
$6.42 - $8.83 $4.99 Million - $6.87 Million
777,568 Added 149.67%
1,297,094 $10.8 Million
Q3 2024

Nov 08, 2024
BUY
$6.42 - $8.83 $4.99 Million - $6.87 Million
777,568 Added 149.67%
1,297,094 $10.8 Million
Q2 2024

Dec 26, 2024
SELL
$5.36 - $7.11 $4.17 Million - $5.53 Million
-777,568 Reduced 59.95%
519,526 $3.3 Million
Q2 2024

Aug 12, 2024
BUY
$5.36 - $7.11 $522,080 - $692,535
97,403 Added 23.07%
519,526 $3.3 Million
Q1 2024

Dec 26, 2024
SELL
$5.24 - $6.34 $4.58 Million - $5.55 Million
-874,971 Reduced 67.46%
422,123 $2.56 Million
Q1 2024

May 10, 2024
BUY
$5.24 - $6.34 $1.24 Million - $1.5 Million
236,082 Added 126.9%
422,123 $2.56 Million
Q4 2023

Dec 26, 2024
SELL
$3.36 - $6.21 $3.73 Million - $6.9 Million
-1,111,053 Reduced 85.66%
186,041 $1.13 Million
Q4 2023

Feb 12, 2024
SELL
$3.36 - $6.21 $1.35 Million - $2.49 Million
-400,718 Reduced 68.29%
186,041 $1.13 Million
Q3 2023

Nov 14, 2023
BUY
$2.76 - $4.59 $149,672 - $248,911
54,229 Added 10.18%
586,759 $2.48 Million
Q2 2023

Aug 11, 2023
BUY
$1.33 - $3.1 $288,866 - $673,298
217,193 Added 68.88%
532,530 $1.65 Million
Q1 2023

May 18, 2023
BUY
$1.27 - $2.7 $100,195 - $213,013
78,894 Added 33.37%
315,337 $438,000
Q1 2023

May 11, 2023
SELL
$1.27 - $2.7 $89,660 - $190,617
-70,599 Reduced 22.99%
236,443 $328,000
Q4 2022

Feb 13, 2023
SELL
$1.96 - $2.61 $121,361 - $161,608
-61,919 Reduced 16.78%
307,042 $611,000
Q3 2022

Nov 14, 2022
SELL
$2.02 - $3.62 $10,988 - $19,692
-5,440 Reduced 1.45%
368,961 $745,000
Q2 2022

Aug 11, 2022
BUY
$3.01 - $4.46 $33,158 - $49,131
11,016 Added 3.03%
374,401 $1.19 Million
Q1 2022

May 11, 2022
BUY
$3.9 - $4.89 $3,350 - $4,200
859 Added 0.24%
363,385 $1.52 Million
Q4 2021

Feb 10, 2022
SELL
$3.95 - $5.85 $47,984 - $71,065
-12,148 Reduced 3.24%
362,526 $1.74 Million
Q3 2021

Nov 12, 2021
BUY
$4.31 - $5.64 $1.61 Million - $2.11 Million
374,674 New
374,674 $2 Million

Others Institutions Holding AMRX

# of Institutions
205
Shares Held
123M
Call Options Held
362K
Put Options Held
141K
View Full List

About Amneal Pharmaceuticals, Inc.

AMRX Quotes by TradingView
  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.31B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email